Is etoricoxib effective in preventing heterotopic ossification after primary total hip arthroplasty? [electronic resource]
Producer: 20131018Description: 583-7 p. digitalISSN:- 1432-5195
- Administration, Oral
- Adult
- Aged
- Aged, 80 and over
- Arthroplasty, Replacement, Hip -- adverse effects
- Cyclooxygenase 2 Inhibitors -- administration & dosage
- Dose-Response Relationship, Drug
- Etoricoxib
- Female
- Hip Joint -- diagnostic imaging
- Hip Prosthesis
- Humans
- Male
- Middle Aged
- Ossification, Heterotopic -- etiology
- Osteoarthritis, Hip -- surgery
- Prospective Studies
- Pyridines -- administration & dosage
- Radiography
- Severity of Illness Index
- Sulfones -- administration & dosage
- Treatment Outcome
No physical items for this record
Publication Type: Clinical Trial, Phase II; Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.